Markets
← Back to Stocks
RVTY
REVVITY INC
Health Care · Health Care Equipment
$85.77
+0.88%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
Revvity trades flat after hours as AI platform launch offsets earnings concerns.
Revvity remained unchanged in after-hours trading on March 18, despite mixed Q3 fundamentals including a 2.1% YoY revenue increase offset by declining earnings concerns. The launch of the AI-driven Signals Xynthetica platform aims to enhance molecular discovery capabilities. Analysts maintain a Buy rating with average 12-month price target of $117.43 (21.20% upside from latest price of $87.37 USD).
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$9.7B
P/E (TTM)41.6
Forward P/E14.3
Beta1.11
Div Yield33.00%
Prev Close$85.02
RSI (14-Day)
26Oversold
0305070100
52-Week Range
$81.36$85.77$118.30
From High-27.5%
From Low+5.4%
Moving Averages
50d SMA
$100.87-15.0%
200d SMA
$95.45-10.1%
Price below 200d MA — bearish structure.
Returns
1W
+1.2%
1M
-12.3%
3M
-10.8%
6M
+0.6%
1Y
-23.7%
YTD
-12.6%
Volume
Today33K
20d Avg1.1M
Ratio0.03x